Myonex’s Post

Did you miss Benedict Hirth’s “Is Clinical Supply the Weakest Link in Your Chain” presentation at Clinical Outsourcing Group New England?  You’ve got an opportunity to catch his presentation as a webinar! Understand the significant risks and consequences of a poorly managed clinical supply chain. Mitigate risks through proactive supply chain management strategies and how to identify potential risks ahead of time. 📅 Date: Thursday, May 23, 2024  ⏰ Time: 11 AM EDT (NA) / 4 PM BST (UK) / 5 PM CEST (EU-Central) 👉 Register now at: https://bit.ly/4dK4vcj #ClinicalTrials #ClinicalTrialSupply #Webinar #Myonex #COGNE  

We're proud to share that James Lovett, Myonex CEO, has been nominated for the Life Sciences & Healthcare CEO category at the 2024 Philadelphia Alliance for Capital and Technologies (PACT) Awards. Starting as a small team in Norristown, PA, Myonex has grown into a global leader with over 400 employees. This growth has been fueled by our unwavering commitment to partnering with our clients to enhance their clinical trials and patient care worldwide. Our recent expansions, including the acquisitions of Creapharm, a Myonex company, and Saveway Compounding Pharmacy, a Myonex company, highlight our continued dedication to being the fastest, most flexible and reliable partner in the clinical trial industry. We’re excited to celebrate this milestone—join us at the awards ceremony on May 21st! RSVP here: https://bit.ly/4d9I67R. #PACTAwards #HealthcareLeadership #Myonex #Innovation #ClinicalTrials #ClinicalTrialSupply

Enjoying Global Clinical Supplies Group - GCSG with some of our future team members from CREAPHARM BIO&PHARMA* at booths 14 and 15! We're discussing the benefits of expanded services across clinical trial supply (including our exclusive solution CTRx) and our newest pharmacy acquisition, Saveway Compounding Pharmacy, a Myonex company. Stop by the booth now or contact a team member to talk through your project needs and see where our services can support you. *The completion of the acquisition is subject to regulatory approvals.

With our recent announcement of our agreement to acquire CREAPHARM BIO&PHARMA’s clinical packaging & distribution and commercial packaging business and bioservices, comes expanded packaging solutions for your projects: ☑️ ATMPs Supply Chain Management: Expert handling of biotherapies, ensuring integrity from storage to distribution. ☑️ Global Reach, Local Touch: With an extended global presence, we're bringing you closer to your markets while maintaining that personalized service you love. ☑️ Streamlined Efficiency: Bundle your packaging needs with Myonex’s other services for a smoother, more cost-effective process. Let's discuss how our new combined capabilities can elevate your next project’s clinical trial supply: https://bit.ly/48TKOuL The completion of this transaction is subject to regulatory approvals. #Myonex #PackagingExcellence #Innovation #ClinicalTrialsPackaging #Clinical Trials #ContractPackaging

Last week, we were thrilled to announce that Myonex entered into an agreement to acquire CREAPHARM BIO&PHARMA’s clinical packaging & distribution and commercial packaging businesses. This strategic move will combine our expertise in clinical trial supply with Creapharm's clinical trials and enhanced packaging and distribution capabilities, providing innovative, global solutions for the industry. Together, we aim to enhance our service offerings and better support our clients' evolving needs through faster, more flexible, and reliable services. 🔎 Read more about how our services and capabilities are expanding here: https://bit.ly/48TKOuL The completion of this transaction is subject to regulatory approvals. #ClinicalTrials #ClinicalTrialSupply #MergersandAcquisition #ClinicalTrialPackaging

🎉 Exciting news from Myonex! Myonex has reached an agreement with the owners of Creapharm Group to acquire the Creapharm Clinical Packaging & Distribution and Commercial Packaging business and bioservices headquartered in Reims, France. The completion of this transaction is subject to regulatory approvals. This strategic acquisition will bring complementary strengths to the marketplace. CREAPHARM BIO&PHARMA will bring scale and deep expertise in clinical packaging and distribution alongside existing franchises in commercial packaging and advanced therapy medicinal products (ATMPs) supply chain management. 👉 Read about this announcement and how it expands our services here: https://bit.ly/48TKOuL #Myonex #ClinicalTrialSupply